DDX53 and neoplasm: As seen before, the mere presence of a CT26 tumor in a mouse already stimulated a tumor specific CD8+ T cell response capable of retarding tumor growth in reconstituted Rag1−/−mice (Figure 3B; group: “CD8+ T cells (CT26)”).